Helicobacter pylori infection in children: prevalence, diagnosis and treatment outcome

Manisha Singh1, Kashi N Prasad, Surender K Yachha

  • 1Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India.

Insights

Helicobacter pylori infection is common in children with upper abdominal pain, increasing with age. Eradicating H. pylori (Helicobacter pylori) effectively resolves symptoms in most children.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • The clinical significance and prevalence of Helicobacter pylori (H. pylori) infection in children are not well-established.
  • Age-specific acquisition rates and reliable diagnostic methods for H. pylori in pediatric gastroduodenal disease require further investigation.

Purpose of the Study:

  • To prospectively determine the prevalence of H. pylori infection in children.
  • To assess the association between H. pylori infection and gastroduodenal disease, specifically upper abdominal pain (UAP).

Main Methods:

  • Evaluated 240 children undergoing upper gastrointestinal endoscopy.
  • Utilized rapid urease test, culture, ureA PCR, and histopathology for H. pylori detection.
  • Compared H. pylori prevalence in children with UAP (n=58) versus controls (n=182).

Main Results:

  • H. pylori infection was significantly higher in children with UAP (53.4%) compared to controls (28%) (P<0.001).
  • Overall H. pylori prevalence increased with age.
  • Eradication therapy was successful in 82% after the first regimen and 100% after a second regimen, with sustained symptom relief.

Conclusions:

  • H. pylori infection is strongly linked to upper abdominal pain in children and its prevalence increases with age.
  • Successful eradication of H. pylori leads to long-term symptom resolution in pediatric patients.
  • Chronic inflammation is a consistent finding in H. pylori-infected children.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...